trichlorosucrose has been researched along with Diabetes Mellitus, Type 2 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Almeda-Valdes, P; Battault, S; Briand, L; Meyer, G; Risdon, S; Romo-Romo, A; Roustit, M; Walther, G | 1 |
| Grotz, VL; Pi-Sunyer, X; Porte, D; Richard Trout, J; Roberts, A | 1 |
| Alcántara-Suárez, R; Baltazar-López, N; Bueno-Hernández, N; Carrero-Aguirre, M; De León, KL; Escobedo, G; Esquivel-Velázquez, M; Gómez-Arauz, AY; Islas-Andrade, S; Manjarrez-Reyna, AN; Martínez-Reyes, CP; Meléndez, G; Méndez-García, LA; Palomera, LF; Ruiz-Barranco, A | 1 |
| Chukwuma, CI; Dlamini, SN; Ibrahim, MA; Islam, MS; Mchunu, N; Oyebode, OA | 1 |
| Argyri, K; Kapsokefalou, M; Papazafiropoulou, A; Psarou, E; Sotiropoulos, A; Zampelas, A | 1 |
| Arpa, M; Deyneli, O; Gunes, M; Haklar, G; Imeryuz, N; Sirikci, O; Temizkan, S; Yasar, M; Yavuz, DG; Yazici, D | 1 |
| Khan, SA | 1 |
| Alemón-Medina, R; Chávez-Pacheco, JL; García-Álvarez, R; Manuel Dávila-Borja, V; Ramírez-Mendiola, B; Rivera-Espinosa, L; Sámano-Salazar, C | 1 |
| Clifton, PM; Gallagher, C; Keogh, JB; Pedersen, E | 1 |
| Grotz, VL; Henry, RR; McGill, JB; Pi-Sunyer, FX; Prince, MJ; Shamoon, H; Trout, JR | 1 |
| Allison, DB; Koch, P; Maggio, CA; Mezitis, NH; Pi-Sunyer, FX; Quddoos, A | 1 |
2 review(s) available for trichlorosucrose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Sucralose and Cardiometabolic Health: Current Understanding from Receptors to Clinical Investigations.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Non-Nutritive Sweeteners; Sucrose | 2021 |
Artificial sweeteners: safe or unsafe?
Topics: Aspartame; Diabetes Mellitus, Type 2; Dipeptides; Humans; Neoplasms; Obesity; Saccharin; Sucrose; Sweetening Agents; Thiazines; Weight Gain | 2015 |
6 trial(s) available for trichlorosucrose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Glycated Hemoglobin; Homeostasis; Humans; Insulin; Male; Sucrose; Sweetening Agents | 2017 |
A Single 48 mg Sucralose Sip Unbalances Monocyte Subpopulations and Stimulates Insulin Secretion in Healthy Young Adults.
Topics: Adult; Blood Glucose; CD11c Antigen; Diabetes Mellitus, Type 2; Eating; Female; Glucose Tolerance Test; Healthy Volunteers; Humans; Insulin; Lectins, C-Type; Male; Mannose Receptor; Mannose-Binding Lectins; Monocytes; Receptors, Cell Surface; Sucrose; Young Adult | 2019 |
Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes.
Topics: Adult; Area Under Curve; Aspartame; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Healthy Volunteers; Humans; Insulin; Male; Middle Aged; Sucrose; Sweetening Agents | 2015 |
Fructose acute effects on glucose, insulin, and triglyceride after a solid meal compared with sucralose and sucrose in a randomized crossover study.
Topics: Adult; Area Under Curve; Australia; Blood Glucose; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructose; Glycemic Index; Humans; Insulin; Male; Meals; Middle Aged; Obesity; Overweight; Postprandial Period; Risk Factors; Sucrose; Sweetening Agents; Triglycerides | 2016 |
Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Homeostasis; Humans; Male; Middle Aged; Patient Compliance; Sucrose; Sweetening Agents | 2003 |
Glycemic effect of a single high oral dose of the novel sweetener sucralose in patients with diabetes.
Topics: Administration, Oral; Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Homeostasis; Humans; Male; Middle Aged; Sucrose; Sweetening Agents | 1996 |
3 other study(ies) available for trichlorosucrose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Commercially available non-nutritive sweeteners modulate the antioxidant status of type 2 diabetic rats.
Topics: Animals; Antioxidants; Aspartame; Catalase; Diabetes Mellitus, Type 2; Glutathione; Glutathione Reductase; Humans; Male; Non-Nutritive Sweeteners; Rats; Rats, Sprague-Dawley; Saccharin; Sucrose; Superoxide Dismutase | 2019 |
Dessert formulation using sucralose and dextrin affects favorably postprandial response to glucose, insulin, and C-peptide in type 2 diabetic patients.
Topics: Aged; C-Peptide; Dextrins; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Glucose; Humans; Insulin; Male; Middle Aged; Postprandial Period; Sucrose; Sweetening Agents | 2013 |
Extemporaneous Formulations of Metformin for Pediatric Endocrinology: Physicochemical Integrity, Cytotoxicity of Sweeteners, and Quantitation of Plasma Levels.
Topics: Administration, Oral; Adult; Cell Line, Tumor; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; MCF-7 Cells; Metformin; Pharmaceutical Solutions; Sucrose | 2015 |